Demir, L. Et Al. 2020. A Real-World Comparison of Pazopanib Versus Sunitinibin Metastatic Renal Cell Carcinoma:Focus on Poor-Risk patients, A Single-Center Study. Journal of oncological sciences , vol.6, no.3 , 153-163.

Demir, L., Bayır, D., Ozdogan, R., Yıldız, B., & Dincer, M., (2020). A Real-World Comparison of Pazopanib Versus Sunitinibin Metastatic Renal Cell Carcinoma:Focus on Poor-Risk patients, A Single-Center Study. Journal of oncological sciences , vol.6, no.3, 153-163.

Demir, LÜTFİYE Et Al. "A Real-World Comparison of Pazopanib Versus Sunitinibin Metastatic Renal Cell Carcinoma:Focus on Poor-Risk patients, A Single-Center Study," Journal of oncological sciences , vol.6, no.3, 153-163, 2020

Demir, LÜTFİYE Et Al. "A Real-World Comparison of Pazopanib Versus Sunitinibin Metastatic Renal Cell Carcinoma:Focus on Poor-Risk patients, A Single-Center Study." Journal of oncological sciences , vol.6, no.3, pp.153-163, 2020

Demir, L. Et Al. (2020) . "A Real-World Comparison of Pazopanib Versus Sunitinibin Metastatic Renal Cell Carcinoma:Focus on Poor-Risk patients, A Single-Center Study." Journal of oncological sciences , vol.6, no.3, pp.153-163.

@article{article, author={LÜTFİYE DEMİR Et Al. }, title={A Real-World Comparison of Pazopanib Versus Sunitinibin Metastatic Renal Cell Carcinoma:Focus on Poor-Risk patients, A Single-Center Study}, journal={Journal of oncological sciences}, year=2020, pages={153-163} }